Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)

Background: Recent studies have demonstrated the utility of cell-free tumor DNA (ctDNA) from plasma as an alternative source of genomic material for detection of sensitizing and resistance mutations in NSCLC. We hypothesized that the plasma level of ctDNA is an effective biomarker to provide a non-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Agulnik, Jason S., Papadakis, Andreas I., Pepe, Carmela, Sakr, Lama, Small, David, Wang, Hangjun, Kasymjanova, Goulnar, Spatz, Alan, Cohen, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871000/
https://www.ncbi.nlm.nih.gov/pubmed/35200593
http://dx.doi.org/10.3390/curroncol29020094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871000/
https://www.ncbi.nlm.nih.gov/pubmed/35200593
http://dx.doi.org/10.3390/curroncol29020094

Ejemplares similares